Huasen Pharmaceutical (002907)
Overview
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 a
Employees1439
Market Cap$5.0B
Revenue$800.0M
Listed OnShenzhen Stock Exchange
Ticker002907
CEOMs. Xiaoying Liu
HeadquartersChongqing